Health Canada releases first drug review, on Diane-35

Health Canada’s recent short summary of Diane 35 raises more questions than it answers, according to an article in the Toronto Star. Drug safety researcher Barbara Mintzes called the assessment “highly problematic” and “quite limited” in scope.

Diane-35 has been linked to several deaths of young women in Canada. About 40,000 Canadian women are on the pill, which is approved for what is considered otherwise untreatable acne, Health Canada has reported.